Tetrabenazine-d6

CAS : 1392826-25-3

Ref. 3D-FT167152

Informations sur le produit

• Nom: Tetrabenazine-d6
• CAS: 1392826-25-3

Description

Tetrabenazine is a drug that is used to treat Parkinson's disease. It decreases the release of dopamine, which can reduce symptoms such as tremors and rigidity. Tetrabenazine has been shown to be an effective treatment for Parkinson's disease in clinical trials with long-term efficacy. Tetrabenazine also has a number of side effects, including hypotension, hallucinations, and depression.br>Tetrabenazine can interact with other drugs or medications such as monoamine oxidase inhibitors, antidepressants, or antipsychotics. This medication should not be taken by people who have liver impairment, because it may lead to liver damage.
br>Tetrabenazine is a drug that belongs to the class of pharmacological agents known as selective monoamine reuptake inhibitors (SSRIs). These agents work by blocking the reuptake of serotonin (5-HT), dopamine (DA), or norepinephrine (NE) into the pres

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 323.46 g/mol
• Formule: C₁₉H₂₁D₆NO₃
• Degré de pureté: Min. 95%